Skip to main content
OpenTrials

Clinical trial condition

Urination Disorders

Explore clinical trials studying Urination Disorders. Study availability and eligibility vary by location and protocol.

1,735 public trials 215 recruiting studies
Refine in advanced search Browse all conditions

Urination Disorders trial results

Completed

An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence

NCT00080470

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Arizona Health Sciences Center (University of Arizona) Tucson, Arizona, United States
  • The Department of Urology, Stanford University Medical Center Stanford, California, United States
  • Milestone Medical Research Englewood, Colorado, United States
  • Bladder Control Center of Norwalk Norwalk, Connecticut, United States
View Trial Details
Completed

The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

NCT00446862

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Emory University Atlanta, Georgia, United States
  • Feinberg School of Medicine, Northwestern University Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

A Research Study for Patients With Overactive Bladder

NCT00168454

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Pittsburgh, Pennsylvania, United States
  • Ghent, Belgium
  • Victoria, British Columbia, Canada
  • Berlin, Germany
View Trial Details
Completed

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

NCT01356849

Conditions
Chronic Disease, Chronic Kidney Disease, Diabetes Complications, +19 more
Locations
  • Site Reference ID/Investigator# 46345 Pell City, Alabama, United States
  • Site Reference ID/Investigator# 46035 Tempe, Arizona, United States
  • Site Reference ID/Investigator# 46016 Azusa, California, United States
  • Site Reference ID/Investigator# 45992 Chula Vista, California, United States
View all 72 locations
View Trial Details
Completed

Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate

NCT00632138

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +22 more
Locations
  • Tameside General Hospital Ashton-under-Lyne, England, United Kingdom
  • Southmead Hospital Bristol, England, United Kingdom
  • Bristol Royal Infirmary Bristol, England, United Kingdom
  • Mid Cheshire Hospitals Trust- Leighton Hopsital Crewe, England, United Kingdom
View all 37 locations
View Trial Details
Completed

Value of Urodynamic Evaluation

NCT00803959

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California San Diego, California, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • University of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

Prenatal Pelvic Floor Prevention (3PN)

NCT00551551

Conditions
Anal Incontinence, Behavior, Behavioral Symptoms, +19 more
Locations
  • CHR Réunion, CH Félix-Guyon Saint-Denis, Réunion, France
  • CHU Antoine-Béclère Clamart, France
  • CHU Clermont Clermont-Ferrand, France
  • CHU Caremeau Nîmes, France
View Trial Details

Related conditions